UK: Working Differently – Will Telehealth Finally Have Its Moment In The Sun?

Last Updated: 28 November 2013
Article by Karen Taylor

Most Read Contributor in UK, August 2017

Our December 2012 report, Telecare and telehealth – a game changer for health and social care, provided a synopsis of the available evidence on the costs and benefits of telehealth and came out firmly in support of the NHS needing to use such technology in its interface with service users. We concluded that technology assisted care provided an equitable way of enabling more people to live independently for longer, while supporting health and social care providers to work differently.  (View the infographic   used to introduce this report or view the video). 

In the past year there has been an unrelenting number of reports, often contradictory, and mostly derived from academic reviews of the Whole System Demonstrator (WSD) remote monitoring trial which have resulted in confusion as to the benefits or otherwise of telehealth.  Nevertheless, in publishing the refreshed Mandate to the NHS last week, the Government continued to champion a key objective in the 2012 Mandate, namely that by 2017 'significant progress will be made towards the 3 million people with long-term conditions being able to benefit from telehealth and telecare'. Clinicians and patients, however, appear to have other ideas. Indeed, a recent survey of Clinical Commissioning Groups (CCGs) suggested that delays and lack of interest from clinicians and patients have undermined progress on rolling out telehealth and that some CCGs were withdrawing their investment.

In light of this confusion, I thought this might be a timely opportunity to review what's been happening over the past 12 months and reflect on the Centre's position on this issue.  On balance, I remain convinced that the messages in our report remain sound and that there is strong evidence to support the wider scale adoption of telehealth, including how best to implement it and under which circumstances it works best. Of increasing relevance is the fact that the pace of technological development means that the technology supporting telehealth is now almost unrecognisable from what was available at the time the WSD trial commenced.  It is far more efficacious and far cheaper; it can be deployed much faster and, for many more conditions, opening up many more possibilities than those in the WSD trial. 

There is also much more clarity and experience in implementing the technology.  In the WSD  trial the two systems were run side by side –  one for those in the trial, and one for the rest – leading to increased operational costs.  However, providers are increasingly seeing telehealth as part of an overall system change and not simply seen as an intervention.  In retrospect, as impressive as it was, there were weaknesses in the way the WSD trial.  Furthermore,  telehealth Apps can now be downloaded  onto a smartphone which significantly reduces upfront costs and provides a mobile, instantly available, service; compared to the WSD, when the telecoms provider had to install a broadband line (and then only once the application form was completed correctly).  As a result, telehealth can now be used to facilitate early discharge from hospital much more easily; which couldn't really be contemplated when the trial was being designed and the types of interventions finalised.

The fact that the WSD was a rigorous RCT also placed significant restrictions on selection of patients and subsequent interactions once patients had been allocated to the intervention or control groups.  Patient selection also excluded many of the neediest people from involvement in the trial; for example people with existing telecare installations, many of whom were likely to have had the highest need, were excluded because they already had technology assistance. There was also bias in the recruitment process because two of the categories of users who we now believe would have benefitted the most (people requiring 'waking night' care, and people caring for those with dementia that were prone to wander) were excluded.

This inevitably meant that the headline results of the WSD were disappointing compared to the results now being seen from using telehealth as part of a whole system intervention, even though the evaluation method is less rigorous (typically before-and-after).  Given the above, I believe that we now need now to move away from a focus on the WSD trial to identifying ways of using the technology more effectively. Continually, looking backwards proves simply that we were at a much earlier stage in technology development and use.

Indeed, all three WSD sites have subsequently mainstreamed telehealth which suggests they are convinced of its value.  For example, in Newham the business case was founded primarily on improved efficiencies in the use of clinical staff, rather than the results of the WSD trial. Indeed, helping staff to work differently was the focus of the Centre's Telehealth report and one that we believe remains key to the challenge of meeting the increasing demand for good quality healthcare services from our ageing population.

A main barrier which is often cited as a barrier to the deployment of telehealth is funding; however, in April 2013, NHS England introduced a Remote Care Monitoring Directly Enhanced Service (DES) payment. Survey responses from 71 CCGs suggest 85% of practices will access the DES this year. Whether this shows true faith in telehealth remains to be seen, however, in adopting the DES specification GP practices will soon find themselves fully involved in the telehealth roll-out. They will have the chance to evaluate the benefits and savings themselves and, given that budget pressures are forcing CCGs to get tough on schemes that do not deliver, could result in those schemes which do work being shared more widely.

As things stand currently, three million users is a long way away but the stage is set for telehealth to stand or fall over the next few years. Championed by the English Government, deployed at scale in Scotland and Northern Ireland, the time has come for healthcare to finally embrace  a technological approach to providing a more effective, convenient and personalised approach to care. But the questioning by critics over a perceived lack of evidence means it still has the potential to become a divisive issue at a time of straighten budgets and pressured services.  If the naysayers prevail, the opportunity to truly transform healthcare and enable it to stand alongside other service industries that have led the way in embracing the technological revolution in their daily interaction with service users, will be lost.  However, if the opportunities are embraced at scale, telehealth may finally have its moment in the sun.

Karen Taylor
Research Director, Deloitte UK Centre for Health Solutions

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.